Blair William & Co. IL Sells 15,134 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Blair William & Co. IL reduced its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 12.4% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 107,010 shares of the medical instruments supplier’s stock after selling 15,134 shares during the period. Blair William & Co. IL’s holdings in DENTSPLY SIRONA were worth $2,031,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of the business. Nordea Investment Management AB increased its position in DENTSPLY SIRONA by 245.0% during the fourth quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier’s stock worth $4,754,000 after acquiring an additional 178,639 shares during the period. JPMorgan Chase & Co. increased its holdings in shares of DENTSPLY SIRONA by 206.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock worth $49,990,000 after purchasing an additional 1,244,326 shares during the period. Bank of New York Mellon Corp raised its position in shares of DENTSPLY SIRONA by 27.9% during the fourth quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier’s stock valued at $45,611,000 after buying an additional 523,692 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of DENTSPLY SIRONA by 1.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier’s stock valued at $39,880,000 after buying an additional 35,360 shares during the period. Finally, Barclays PLC grew its position in DENTSPLY SIRONA by 21.8% during the third quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock worth $8,301,000 after buying an additional 54,920 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Down 1.9 %

Shares of NASDAQ XRAY opened at $14.65 on Wednesday. DENTSPLY SIRONA Inc. has a 12-month low of $14.61 and a 12-month high of $33.02. The firm’s 50-day simple moving average is $17.55 and its 200 day simple moving average is $20.05. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The company has a market cap of $2.92 billion, a price-to-earnings ratio of -7.08, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.16 per share. The ex-dividend date is Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 4.37%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -14.07%.

Insider Activity at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier acquired 15,142 shares of the firm’s stock in a transaction on Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the transaction, the director now owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.52% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of brokerages recently commented on XRAY. Evercore ISI restated an “in-line” rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Needham & Company LLC reaffirmed a “hold” rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Barrington Research lowered their target price on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research note on Friday, February 28th. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and dropped their price target for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. Finally, Wells Fargo & Company lowered their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating on the stock in a research note on Friday, February 28th. Twelve analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $23.33.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.